Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
11
×
boston blog main
deals
11
×
life sciences
national blog main
boston top stories
clinical trials
fda
investing
national top stories
san francisco blog main
roche
startups
san francisco top stories
alexion pharmaceuticals
autoimmune disorders
medical device
new york blog main
new york top stories
perceptive advisors
480 biomedical
abbott laboratories
abbvie
adel malek
akouos
allergan
allosteric
alnylam pharmaceuticals
alzheimer's disease
amyotrophic lateral sclerosis (als)
arsenal medical
astellas pharmaceuticals
atlas venture
aton partners
atopic dermatitis
avapritinib
azacitidine
beta-thalassemia
biofourmis
What
medicines
therapeutics
drug
new
biotech
developing
disease
fda
gene
research
roche
treat
address
approval
called
candidate
deal
ipo
million
pact
pharma
pharmaceuticals
potential
raised
startup
team
abbvie
absorb
adds
affects
ago
aims
alliance
allosteric
alternative
americans
analytics
approach
approved
autoimmune
Language
unset
11
×
Current search:
unset
×
boston
×
deals
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds